Drugs / K-161
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial · 1 missed | ||||||
| Phase 2 | NCT04084483 | Aug 2019 → Jan 2020 | dry eye syndrome | Kowa Research Institute, Inc. | Completed | Missed primary |
| Phase 31 trial · 1 missed | ||||||
| Phase 3 | NCT05403827 | Jul 2022 → Aug 2023 | dry eye syndrome | Kowa Research Institute, Inc. | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | K-161 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04084483 ↗ |